Rankings
▼
Calendar
CRMD Q1 2022 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$536M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7,636
-91.3% YoY
Gross Profit
$6,109
80.0% margin
Operating Income
-$7M
-92094.8% margin
Net Income
-$7M
-92142.8% margin
EPS (Diluted)
$-0.18
QoQ Revenue Growth
-86.5%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$65M
Total Liabilities
$5M
Stockholders' Equity
$60M
Cash & Equivalents
$45M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7,636
$88,261
-91.3%
Gross Profit
$6,109
$26,922
-77.3%
Operating Income
-$7M
-$7M
+2.5%
Net Income
-$7M
-$7M
+2.5%
← FY 2022
All Quarters
Q2 2022 →